Estimating the Age of Disease-causal HPV Infection Based on the Natural History of CIN2+ Among Females in Canada
The analysis indicates a substantial percentage of causal HPV infections for CIN2+ occur among women aged 26 years or older. Extending catch-up vaccination programs to women above age 26 years should be considered to prevent these infections and reduce HPV-related cervical diseases.
Authors
- Xuedan You (ORCID: https://orcid.org/0000-0002-2551-9111)
- Abdallah Cherif
- Ying‐Ting Chen (ORCID: https://orcid.org/0000-0002-8606-2418)
- Miriam Reuschenbach (ORCID: https://orcid.org/0000-0003-4268-6250)
- Gargi Baluni
- Brian Murphy (ORCID: https://orcid.org/0000-0001-7784-3434)
- Mukesh Yadav (ORCID: https://orcid.org/0000-0002-4703-8554)
- Craig S. Roberts (ORCID: https://orcid.org/0000-0002-5852-9770)
- Edward W. Hillhouse
- Jeremy J. Cook
- Shashank Gotarkar
- Eduardo Luis Franco (ORCID: https://orcid.org/0000-0002-4409-8084)
- R. A. Stone
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- McGill University Health Centre (CA)
- Merck Canada Inc. (Canada) (CA)
- MSD (Germany) (DE)
- Institute of Computational Modeling (RU)
- McGill University (CA)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1093/ofid/ofaf168
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00